1.中国人民解放军联勤保障部队第967医院中医血液科(辽宁 大连 116021)
梁颖,女,硕士,主治医师,主要从事中西医结合治疗白血病、淋巴瘤、骨髓增殖性肿瘤的临床与研究工作
陈楠楠,主任医师,硕士研究生导师;E-mail:chnngax@hotmail.com
扫 描 看 全 文
梁颖, 黄世林, 陈楠楠. 黄世林从“骨枯髓虚”论治原发性骨髓纤维化经验[J]. 上海中医药杂志, 2021,55(5):24-26.
Ying LIANG, Shilin HUANG, Nannan CHEN. Huang Shilin’s experience in treating primary myelofibrosis based on the pathological feature of "bone depletion and marrow deficiency"[J]. Shanghai Journal of Traditional Chinese Medicine, 2021,55(5):24-26.
梁颖, 黄世林, 陈楠楠. 黄世林从“骨枯髓虚”论治原发性骨髓纤维化经验[J]. 上海中医药杂志, 2021,55(5):24-26. DOI: 10.16305/j.1007-1334.2021.1906076.
Ying LIANG, Shilin HUANG, Nannan CHEN. Huang Shilin’s experience in treating primary myelofibrosis based on the pathological feature of "bone depletion and marrow deficiency"[J]. Shanghai Journal of Traditional Chinese Medicine, 2021,55(5):24-26. DOI: 10.16305/j.1007-1334.2021.1906076.
介绍黄世林教授从“骨枯髓虚”论治原发性骨髓纤维化的临床经验。认为本病中医病名可为“骨痿”,病理特征为“骨枯髓虚”,毒瘀互结、肾虚精亏为本病之基本病机。治疗方面,黄教授形成了具有辨证分期论治特色的治疗方案,将本病分为毒瘀互结证与肾虚精亏证,分别采用解毒清热、化瘀散结法及扶正祛邪、补肾填精法施治,并区分疾病的进展期与稳定期,采用中西医结合治疗。总之,解毒散瘀、扶正祛邪之法应当贯穿本病治疗的始终。
This paper introduces Professor Huang Shilin’s clinical experience in treating primary myelofibrosis (PMF) based on the pathological feature of "bone depletion and marrow deficiency" .Professor Huang believes that PMF belongs to the category of "Gu Wei" (atrophic debility of bones)in traditional Chinese medicine (TCM), and its pathological feature is "bone depletion and marrow deficiency" . The basic pathogenesis is intermingled toxin and blood stasis, kidney asthenia and essence deficiency. Professor Huang has developed a distinctive treatment plan based on syndrome differentiation and staging treatment. He divides PMF into intermingled toxin and blood stasis syndrome and kidney asthenia and essence deficiency syndrome. The former is treated with the method of removing toxin and clearing heat, removing blood stasis and resolving stagnation; while the latter is treated with the method of strengthening body resistance and eliminating pathogenic factors, consolidating kidney and supplementing essence. Professor Huang also differentiates PMF into progressive stage and stable stage, and adopts integrated traditional Chinese and western medicine for treatment. To sum up, the therapeutic principles of removing toxin and resolving stasis, strengthening body resistance and eliminating pathogenic factors should be followed throughout the whole treatment process.
原发性骨髓纤维化恶性肿瘤血液疾病骨痿解毒散瘀扶正祛邪名医经验黄世林
primary myelofibrosismalignant tumorblood diseasesatrophic debility of bonesremoving toxin and resolving stasisstrengthening body resistance and eliminating pathogenic factorsfamous doctor’s experienceHuang Shilin
中华医学会血液学分会白血病淋巴瘤学组. 原发性骨髓纤维化诊断与治疗中国专家共识(2019年版)[J]. 中华血液学杂志,2019, 40(1): 1-7.
吴文. 原发性骨髓纤维化的诊治进展[J]. 中华临床医师杂志(电子版),2013, 7(5): 1866-1870.
徐俊卿. 原发性骨髓纤维化预后的研究进展[J]. 国际输血及血液学杂志,2012, 35(5): 454-458.
胡宝丹,陈林. 骨髓纤维化研究进展[J]. 现代医药卫生,2021, 37(5): 781-785.
孙淑君,向阳. 黄世林辨治慢性骨髓纤维化[J]. 天津中医药,2010, 27(4): 274-275.
张振会,李建英,吴维海. 吴维海主任医师诊治骨髓纤维化经验研究[J]. 河北中医药学报,2016, 31(4): 49-51.
王剑鹏. 杨淑莲教授治疗原发性骨髓纤维化学术思想总结[C]//中华中医药学会.中华中医药学会第二届岐黄论坛“血液病中医药防治分论坛”论文集. 北京:中华中医药学会血液病中医药防治分论坛工作组,2014: 3.
马传宝,刘清池,吴维海. 骨髓纤维化的中医诊治[J]. 河北中医,2011, 33(10): 1489-1490.
赖宗浪,史雯,马薇,等. 李冬云运用理气活血法治疗骨髓增殖性肿瘤的临床经验[J]. 北京中医药,2014, 33(4): 263-266.
王鸣,杨文华. 杨文华辨治骨髓纤维化经验[J]. 河南中医,2017, 37(10): 1718-1721.
0
浏览量
228
下载量
0
CSCD
2
CNKI被引量
关联资源
相关文章
相关作者
相关机构